Johnson & Johnson (NYSE:JNJ)

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.00 in earnings per ...
Read Full Story »

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. The Dow is hovering near its all-time high, just as this ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Stocks were indicated to open sharply higher on Brexit hopes and U.S./China trade hopes, and earnings season will kick off next week. The bull market is now well over 10 ...
Read Full Story »

Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling

The announcement that a jury has awarded $8 billion in damages to a man accusing Johnson & Johnson (NYSE: JNJ) of failing to warn about the side effects of ...
Read Full Story »

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

Johnson & Johnson (NYSE: JNJ) surprised investors on Wednesday morning by announcing a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial. While this in and ...
Read Full Story »

Unusual Settlement Deal Proposed for Opioid Lawsuits

Five pharmaceuticals makers are proposing an unusual method for settling hundreds of the more than 2,500 lawsuits facing drugmakers that made and sold opioid painkillers. The five companies want to ...
Read Full Story »

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

With just over one quarter left in 2019, it has been another banner year for stock market investors, with double-digit gains in all three major averages. Barring a big end-of-the-year ...
Read Full Story »

As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus

With all the talk of trade war, recessions, inverted yield curves and negative interest rates in August and the start of September, many investors have every right to feel duped. ...
Read Full Story »

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

When companies run into legal issues in which they face potentially endless numbers of trials in numerous venues in America, it can create a tough time managing them. Johnson & ...
Read Full Story »

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Johnson & Johnson (NYSE: JNJ) saw its shares get hit after earnings, but it was more than just the earnings and guidance to blame. Along with issues around ongoing talcum ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

Stocks were looking for direction as earnings season gets started. The bull market is now well over 10 years old, and 2019 has seen very strong stock market gains, with ...
Read Full Story »

Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead

One company that has been a champion for investors has been Johnson & Johnson (NYSE: JNJ). The company has grown and grown over the years with sales of consumer products, ...
Read Full Story »

Johnson & Johnson Slides By With Q2 Earnings

When Johnson & Johnson (NYSE: JNJ) reported its most recent quarterly results before the markets opened on Tuesday, the pharmaceutical giant said it had $2.58 in earnings per share (EPS) ...
Read Full Story »

What to Watch When Johnson & Johnson Reports Tomorrow

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.43 in earnings per ...
Read Full Story »